Dynorphin-mediated antinociceptive effects of l-arginine and SIN-1 (an NO donor) in mice

Brain Research Bulletin

Volumn 70, Issue 3, 2006, Pages 245-250

  Chung, Eunhee ^a   Burke, Brianna ^a   Bieber, Andrew J ^a   Doss, Jason C ^a   Ohgami, Yusuke ^a   Quock, Raymond M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Antinociception; Arginine; Dynorphin; Mice; Nitric oxide; NO donors; Opioid

Indexed keywords

ACETIC ACID; ARGININE; DYNORPHIN; DYNORPHIN ANTIBODY; DYNORPHIN[1-13]; LINSIDOMINE; METENKEPHALIN; NALOXONE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITROUS OXIDE; NORBINALTORPHIMINE; RABBIT ANTISERUM;

ABDOMINAL CRAMP; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALGESICS; ANIMALS; ARGININE; BRAIN; DYNORPHINS; ENZYME INHIBITORS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOLSIDOMINE; NALOXONE; NARCOTIC ANTAGONISTS; NITRIC OXIDE DONORS; PAIN MEASUREMENT;

EID: 33745970186     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.05.008     Document Type: Article

References (52)

1. G-nitro-l-arginine binding to neuronal nitric oxide synthase in rat brain. Neurochem. Int. 30 (1997) 605-611
2. Barbul A. Arginine: biochemistry, physiology, and therapeutic implications. J. Parenter. Enteral. Nutr. 10 (1986) 138-227
3. Bhargava H.N., Sharma S.S., and Bian J.T. Evidence for a role of N-methyl-d-aspartate receptors in l-arginine-induced attenuation of morphine antinociception. Brain Res. 782 (1998) 314-317
4. Branda E.M., Ramza J.T., Cahill F.J., Tseng L.F., and Quock R.M. Role of brain dynorphin in nitrous oxide antinociception in mice. Pharmacol. Biochem. Behav. 65 (2000) 217-222
5. Cahill F.J., Ellenberger E.A., Mueller J.L., Tseng L.F., and Quock R.M. Antagonism of nitrous oxide antinociception in mice by intrathecally administered opioid peptide antisera. J. Biomed. Sci. 7 (2000) 299-303
6. Chavkin C., James I.F., and Goldstein A. Dynorphin is a specific endogenous ligand of the κ-opiate receptor. Science 215 (1982) 413-415
7. G-nitro l-arginine. Gen. Pharmacol. 28 (1997) 443-448
8. Corbett A.D., Paterson S.J., McKnight A.T., Magnan J., and Kosterlitz H.W. Dynorphin (1-8) and dynorphin (1-9) are ligands for the κ-subtype of opiate receptor. Nature (Lond.) 299 (1982) 79-81
9. Durate I.D., Lorenzetti B.B., and Ferreira S.H. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur. J. Pharmacol. 186 (1990) 289-293
10. 7-enkephalin into canine third ventricular cerebrospinal fluid. Anesth. Analg. 80 (1995) 664-670
11. Haley T.J., and McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. 12 (1957) 12-15
12. Hara S., Gagnon M.J., Quock R.M., and Shibuya T. Effect of opioid peptide antisera on nitrous oxide antinociception in rats. Pharmacol. Biochem. Behav. 48 (1994) 699-702
13. Hara S., Kuhns E.R., Ellenberger E.A., Mueller J.L., Shibuya T., Endo T., and Quock R.M. Involvement of nitric oxide in intracerebroventricular β-endorphin-induced neuronal release of methionine-enkephalin. Brain Res. 675 (1995) 190-194
14. Harima A., Shimizu H., and Takagi H. Analgesic effect of l-arginine in patients with persistent pain. Eur. Neuropsychopharmacol. 1 (1991) 529-533
15. Haulica I., Busuioc A., Neamtu C., Dorneanu V., Titu G., and Spac A. Possible involvement of the l-arginine-nitric oxide pathway in the modulation of stress-induced analgesia. Funct. Neurol. 10 (1995) 169-173
16. Haulica I., Busuioc A., Neamtu C., Dorneanu V., Titu G., and Spac A. Possible involvement of l-arginine-nitric oxide pathway in the modulation of stress-induced analgesia. Rom. J. Physiol. 34 (1997) 19-24
17. Hayes A.G., Skingle M., and Tyers M.B. Antinociceptive profile of dynorphin in the rat. Life Sci. 33 Suppl. 1 (1983) 657-660
18. Huang C.C., Chan S.H.H., and Hsu K.S. cGMP/protein kinase G-dependent potentiation of glutamatergic transmission induced by nitric oxide in immature rat rostral ventrolateral medulla neurons in vitro. Mol. Pharmacol. 64 (2003) 521-532
19. Inoue M., Mishina M., and Ueda H. Locus-specific rescue of GluRε1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J. Neurosci. 23 (2003) 6529-6536
20. Jayakumar A.R., Rajasekaran K., Subramanian E.H., Paul V., and Harihara E. Possible involvement of nitric oxide in locomotor behaviour in rats. Biomed. Trivandrum Taramani 19 (1999) 215-219
21. Ji X.Q., and Zhu X.Z. Possible involvement of nitric oxide in arginine-induced analgesia. Zhongguo Yao Li Xue Bao 14 (1993) 289-291
22. Kamei J., Iwamoto Y., Misawa M., Nagase H., and Kasuya Y. Antinociceptive effect of l-arginine in diabetic mice. Eur. J. Pharmacol. 254 (1994) 113-117
23. Kaneko T., Nakazawa T., Ikeda M., Yamatsu K., Iwama T., Wada T., Satoh M., and Takagi H. Sites of analgesic action of dynorphin. Life Sci. 33 Suppl. 1 (1983) 661-664
24. Kawabata A., Fukuzumi Y., Fukushima Y., and Takagi H. Antinociceptive effect of l-arginine on the carrageenin-induced hyperalgesia of the rat: possible involvement of central opioidergic systems. Eur. J. Pharmacol. 218 (1992) 153-158
25. Kawabata A., Iwatsubo K., Takaya S., and Takagi H. Central antinociceptive effect of l-ornithine, a metabolite of l-arginine, in rats and mice. Eur. J. Pharmacol. 296 (1996) 23-31
26. Kawabata A., Manabe S., and Takagi H. Comparison of antinociception induced by supraspinally administered l-arginine and kyotorphin. Br. J. Pharmacol. 112 (1994) 817-822
27. Kawabata A., Nishimura Y., and Takagi H. l-Leucyl-l-arginine, naltrindole and d-arginine block antinociception elicited by l-arginine in mice with carrageenin-induced hyperalgesia. Br. J. Pharmacol. 107 (1992) 1096-1101
28. Kawabata A., Tanaka M., Muguruma H., and Takagi H.H. NG-nitro-l-arginine methyl ester and alpha-methyl-l-ornithine inhibit kyotorphin synthetase from rat brain. Peptides 16 (1995) 1317-1319
29. Kawabata A., Umeda N., and Takagi H. l-Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway. Br. J. Pharmacol. 109 (1993) 73-79
30. Kishioka S., Morita N., Kitabata Y., Yamanishi T., Miyamoto Y., Ozaki M., and Yamamoto H. Dynorphin-(1-13): antinociceptive action and its effects on morphine analgesia and acute tolerance. Jpn. J. Pharmacol. 60 (1992) 197-207
31. Kishioka S., Miyamoto Y., Fukunaga Y., Nishida S., and Yamamoto H. Effects of a mixture of peptidase inhibitors (amastatin, captopril and phosphoramidon) on Met-enkephalin-, beta-endorphin-, dynorphin-(1-13)- and electroacupuncture-induced antinociception in rats. Jpn. J. Pharmacol. 66 (1994) 337-345
32. Kumar A., Raghubir R., Srimal R.C., and Dhawan B.N. Evidence for involvement of nitric oxide in pretectal analgesia in rat. Neuroreport 4 (1993) 706-708
33. Kurt S.S., Bilge O., Kukula S., Celik S., and Kesim Y. Anxiolytic-like profile of propofol, a general anesthetic, in the plus-maze test in mice. Pol. J. Pharmacol. 55 (2003) 973-977
34. Masue T., Dohi S., Asano T., and Shimonaka H. Spinal antinociceptive effect of epidural nonsteroidal antiinflammatory drugs on nitric oxide-induced hyperalgesia in rats. Anesthesiology 91 (1999) 198-206
35. McDonald C.E., Gagnon M.J., Ellenberger E.A., Hodges B.L., Ream J.K., Tousman S.A., and Quock R.M. Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats. J. Pharmacol. Exp. Ther. 269 (1994) 601-608
36. Nakazawa T., Ikeda M., Kaneko T., and Yamatsu K. Analgesic effects of dynorphin-A and morphine in mice. Peptides 6 (1985) 75-78
37. Petrie E.C., Tiffany S.T., Baker T.B., and Dahl J.L. Dynorphin (1-13): analgesia, hypothermia, cross-tolerance with morphine and beta-endorphin. Peptides 3 (1982) 41-47
38. Quock R.M., Best J.A., Chen D.C., Vaughn L.K., Portoghese P.S., and Takemori A.E. Mediation of nitrous oxide analgesia in mice by spinal and supraspinal κ-opioid receptors. Eur. J. Pharmacol. 175 (1990) 97-100 (corrigendum 187 (1990) 564)
39. Quock R.M., Curtis B.A., Reynolds B.J., and Quock R.M. Dose-dependent antagonism and potentiation of nitrous oxide antinociception by naloxone in mice. J. Pharmacol. Exp. Ther. 267 (1993) 117-122
40. Quock R.M., Kouchich F.J., and Tseng L.F. Does nitrous oxide induce release of brain opioid peptides?. Pharmacology 30 (1985) 95-99
41. Quock R.M., and Vaughn L.K. Nitrous oxide: mechanism of its analgesic action. Analgesia 1 (1995) 151-159
42. Sahraei H., Pirzadeh-Jahromi G., Noorbakhshnia M., Asgari A., Haeri-Rohani A., Khoshbaten A., Poorheidari G.R., Sepehri H., Ghoshooni H., and Zarrindast M.R. Involvement of nucleus accumbens in l-arginine-induced conditioned place preference in rats. Behav. Pharmacol. 15 (2004) 473-480
43. Shiomi H., Kuraishi Y., Ueda H., Harada Y., Amano H., and Takagi H. Mechanism of kyotorphin-induced release of Met-enkephalin from guinea pig striatum and spinal cord. Brain Res. 221 (1981) 161-169
44. Steinfels G.F., and Cook L. Antinociceptive profiles of opioid peptide agonists in a rat tooth pulp stimulation procedure. Peptides 6 Suppl. 2 (1985) 171-175
45. Summy-Long J.Y., Bui V., Gestl S., Koehler-Stec E., Liu H., Terrell M.L., and Kadekaro M. Effects of central injection of kyotorphin and l-arginine on oxytocin and vasopressin release and blood pressure in conscious rats. Brain Res. Bull. 45 (1998) 395-403
46. Takagi H., Shiomi H., Ueda H., and Amano H. A novel analgesic dipeptide from bovine brain is a possible met-enkephalin releaser. Nature (Lond.) 282 (1979) 410-412
47. Tong B.C., and Barbul A. Cellular and physiological effects of arginine. Mini Rev. Med. Chem. 4 (2004) 823-832
48. Tyers M.B. A classification of opiate receptors that mediate antinociception in animals. Br. J. Pharmacol. 69 (1980) 503-512
49. Ueda H., Yoshihara Y., Fukushima N., Shiomi H., Nakamura A., and Takagi H. Kyotorphin (tyrosyl-arginine) synthetase in rat brain synaptosomes. J. Biol. Chem. 262 (1987) 8165-8173
50. Vaught J.L., and Chipkin R.E. A characterization of kyotorphin (Tyr-Arg)-induced antinociception. Eur. J. Pharmacol. 79 (1982) 167-173
51. Xu J.Y., Pieper G.M., and Tseng L.F. Activation of a NO-cyclic GMP system by NO donors potentiates β-endorphin-induced antinociception in the mouse. Pain 63 (1995) 377-383
52. Zuniga J.R., Joseph S.A., and Knigge K.M. The effects of nitrous oxide on the secretory activity of pro-opiomelanocortin peptides from basal hypothalamic cells attached to cytodex beads in a superfusion in vitro system. Brain Res. 420 (1987) 66-72